Clinical trials
Oropharyngeal Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 4 |
| M.D. Anderson Cancer Center | 4 |
| Gustave Roussy, Cancer Campus, Grand Paris | 3 |
| Rigshospitalet, Denmark | 3 |
| National Cancer Institute (NCI) | 2 |
| University Medical Center Groningen | 2 |
| All India Institute of Medical Sciences | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Chang Gung Memorial Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oropharyngeal Neoplasms | 42 |
| Head and Neck Neoplasms | 18 |
| Hypopharyngeal Neoplasms | 12 |
| Mouth Neoplasms | 12 |
| Laryngeal Neoplasms | 11 |
| Nasopharyngeal Neoplasms | 10 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Salivary Gland Neoplasms | 6 |
| Esophageal Neoplasms | 3 |
| Anus Neoplasms | 2 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.